Usefulness of CA 19–9 for pancreatic cancer screening in patients with new-onset diabetes
ConclusionCA 19–9 levels after a diagnosis of new-onset DM could be a useful biomarker of pancreatic cancer, especially in patients with high serum bilirubin.
Source: Hepatobiliary and Pancreatic Diseases International - Category: Gastroenterology Source Type: research
More News: Bilirubin | Cancer | Cancer & Oncology | Carbohydrates | Diabetes | Diabetes Mellitus | Endocrinology | Pancreas | Pancreatic Cancer | Study